Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

LUMES LUng cancer Metastasis Evolutionary Studies

Project description

Unravelling how cancer spreads in the body

Metastasis is responsible for over 90 % of cancer-related deaths. Despite this significant clinical impact, the mechanisms underlying metastatic dissemination and tumour aggressiveness are incompletely understood. This is partly due to a lack of high-quality samples and analytical tools. The ERC-funded LUMES project aims to address this gap in knowledge through comprehensive analysis of tissue samples from both primary and metastatic tumours. The research team will combine advanced laboratory techniques and artificial intelligence to generate and process genetic data, circulating tumour DNA (ctDNA), as well as contextual information about the tumour environment. Ultimately, this initiative aims to uncover the mechanisms underpinning metastatic progression and to identify new therapeutic avenues.

Objective

Metastatic disease, describing the development of secondary malignant growths at a distance from a primary site of cancer, is associated with over 90% of cancer-related deaths. There exists a significant unmet clinical need to better understand the biology of aggressive cancers leading to metastatic disease and the underlying mechanisms that can facilitate the metastasis. Previous studies exploring metastasis have suffered from scarcity of samples, insufficient resolution and breadth of experimental data, and a lack of appropriate computational and statistical tools. These inadequacies have led to significant ambiguities in data interpretation resulting in a substantial knowledge gap, hindering translational opportunities to tackle metastatic disease.

LUMES will provide crucial contributions towards an in-depth understanding of metastasis by (1) exploiting access to the singular Posthumous Evaluation of Advanced Cancer Environment (PEACE; NCT03004755) research autopsy programme with extensive sampling from both primary and metastatic sites to generate a unique resource for exploration of metastatic cancer evolution, (2) applying cutting-edge experimental techniques to human samples, (3) developing advanced novel AI enhanced computational and statistical tools designed to study metastasis and metastatic spread, (4) applying an integrative view of cancer development, incorporating genetic and non-genetic analysis of cancer-cell intrinsic and extrinsic features as well as ctDNA, in the context of the tumour microenvironment and detailed clinical annotation, including exposure to cancer therapies. Importantly, (1) and (2) provide an indispensable fundament for (3) and (4). The synergies between (3) and (4) are immense. Computational method development and application should be coupled. Our work will enable a deep understanding of the metastatic process and reveal key differences in cancer cell intrinsic and microenvironment between distinct patterns of metastasis.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-SYG - HORIZON ERC Synergy Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-SyG

See all projects funded under this call

Host institution

KUNGLIGA TEKNISKA HOEGSKOLAN
Net EU contribution
€ 1 710 319,00
Address
BRINELLVAGEN 8
100 44 Stockholm
Sweden
Region
Östra Sverige Stockholm Stockholms län
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 710 319,00

Beneficiaries (4)